Treating systemic prostate cancer: emerging drug targets and therapies
Prostate cancer is the most common cancer among men and is the second most common
cause of cancer death. Although more patients are now diagnosed with localised prostate …
cause of cancer death. Although more patients are now diagnosed with localised prostate …
Emerging hormonal agents for the treatment of prostate cancer
E Bochner, S Gold, GV Raj - Expert opinion on emerging drugs, 2022 - Taylor & Francis
Introduction Prostate cancer is the most common solid organ malignancy in men in the
United States. Until recently, treatment options for men with metastatic disease were limited …
United States. Until recently, treatment options for men with metastatic disease were limited …
Novel targeted therapies for prostate cancer
RJ Macfarlane, KN Chi - Urologic Clinics, 2010 - urologic.theclinics.com
Prostate cancer is the most common non–skin cancer diagnosed in North America and
affects 1 in 6 men. It is the second to third most common cause of cancer death in men in the …
affects 1 in 6 men. It is the second to third most common cause of cancer death in men in the …